Client: Zentiva (Digenzym) ·
Agencies: Wisebrand and MAD ·
Market: Romania ·
Vertical: Healthcare (OTC Digestive Supplement) ·
Award: The Wire Awards 2025, Winner, Best Partnership (Media: Use of Data & Insights)
Executive Summary
Wisebrand and MAD used Digiseg’s household-based profiling to monitor audience composition in real time across a winter and a summer flight, then pivoted media and creative mid-flight. CTRs tripled, CPCs fell 40%, and full-year sales rose 41% versus 2023 while the digestive category grew only 5%.
Digiseg was used to monitor audience composition in real time, guiding media and creative decisions.
The Challenge
Launching a new digestive supplement into Romania’s over-the-counter (OTC) market meant going head-to-head with two established category leaders. Zentiva’s Digenzym is a brand distributed through wholesalers and retail pharmacies, without any direct-to-consumer channel or reliable system to track conversions and measure real-time performance. Traditional attribution tactics, retargeting, lookalikes, were unavailable.
The Solution
Rather than seeing this as a handicap, Wisebrand (lead creative, PR, and social) and MAD (performance and paid media) turned constraint into strategy. If sales couldn’t be tracked, audiences could. The team reframed performance: measurement would not be about attribution, but about who was engaging.
Using Digiseg’s household-based profiling, they monitored audience composition in real time across two flights: winter for validation, summer for exploration.
Early results confirmed the holiday season skewed toward older, rural, lower-income households. But summer told a different story: younger, affluent, mobile consumers managing digestive discomfort while traveling. These insights allowed the team to pivot mid-flight.
Media shifted toward TikTok, regional delivery expanded to coastal and mountain tourist zones, TripAdvisor inventory was added, and creative highlighted “packable wellness” for travelers.
Results
The impact was clear. CTRs tripled, CPCs fell 40%, and stock-outs followed within weeks of the pivots. Full-year sales rose +41% versus 2023, while the digestive category grew only +5%.
Digenzym and MAD proved that in an offline category, measurement, not attribution, can guide strategy, validate audiences, and deliver sell-out performance.